Quinlobelane

A water-soluble lobelane analogue and inhibitor of VMAT2

Ashish P Vartak, A. Gabriela Deaciuc, Linda P. Dwoskin, Peter A. Crooks

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Replacing the phenyl groups in the structure of the VMAT2 inhibitor, lobelane with either pyridyl, quinolyl or indolyl groups affords novel analogues with improved water solubility. The synthetic methodologies reported herein also underscore the paucity of hydrogenation methods that offer selectivity in the synthesis of the different classes of heteroaromatic lobelane analogues. The quinolyl group was the only replacement for the phenyl group in lobelane that retained VMAT2 inhibition.

Original languageEnglish (US)
Pages (from-to)3584-3587
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume20
Issue number12
DOIs
StatePublished - May 21 2010

Fingerprint

Water
Hydrogenation
Solubility
lobelane

Keywords

  • Dopamine transport
  • Lobeline analogs
  • VMAT2

Cite this

Quinlobelane : A water-soluble lobelane analogue and inhibitor of VMAT2. / Vartak, Ashish P; Gabriela Deaciuc, A.; Dwoskin, Linda P.; Crooks, Peter A.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 20, No. 12, 21.05.2010, p. 3584-3587.

Research output: Contribution to journalArticle

Vartak, Ashish P ; Gabriela Deaciuc, A. ; Dwoskin, Linda P. ; Crooks, Peter A. / Quinlobelane : A water-soluble lobelane analogue and inhibitor of VMAT2. In: Bioorganic and Medicinal Chemistry Letters. 2010 ; Vol. 20, No. 12. pp. 3584-3587.
@article{dea53d59f56a4320a0b918416214e50f,
title = "Quinlobelane: A water-soluble lobelane analogue and inhibitor of VMAT2",
abstract = "Replacing the phenyl groups in the structure of the VMAT2 inhibitor, lobelane with either pyridyl, quinolyl or indolyl groups affords novel analogues with improved water solubility. The synthetic methodologies reported herein also underscore the paucity of hydrogenation methods that offer selectivity in the synthesis of the different classes of heteroaromatic lobelane analogues. The quinolyl group was the only replacement for the phenyl group in lobelane that retained VMAT2 inhibition.",
keywords = "Dopamine transport, Lobeline analogs, VMAT2",
author = "Vartak, {Ashish P} and {Gabriela Deaciuc}, A. and Dwoskin, {Linda P.} and Crooks, {Peter A.}",
year = "2010",
month = "5",
day = "21",
doi = "10.1016/j.bmcl.2010.04.117",
language = "English (US)",
volume = "20",
pages = "3584--3587",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "12",

}

TY - JOUR

T1 - Quinlobelane

T2 - A water-soluble lobelane analogue and inhibitor of VMAT2

AU - Vartak, Ashish P

AU - Gabriela Deaciuc, A.

AU - Dwoskin, Linda P.

AU - Crooks, Peter A.

PY - 2010/5/21

Y1 - 2010/5/21

N2 - Replacing the phenyl groups in the structure of the VMAT2 inhibitor, lobelane with either pyridyl, quinolyl or indolyl groups affords novel analogues with improved water solubility. The synthetic methodologies reported herein also underscore the paucity of hydrogenation methods that offer selectivity in the synthesis of the different classes of heteroaromatic lobelane analogues. The quinolyl group was the only replacement for the phenyl group in lobelane that retained VMAT2 inhibition.

AB - Replacing the phenyl groups in the structure of the VMAT2 inhibitor, lobelane with either pyridyl, quinolyl or indolyl groups affords novel analogues with improved water solubility. The synthetic methodologies reported herein also underscore the paucity of hydrogenation methods that offer selectivity in the synthesis of the different classes of heteroaromatic lobelane analogues. The quinolyl group was the only replacement for the phenyl group in lobelane that retained VMAT2 inhibition.

KW - Dopamine transport

KW - Lobeline analogs

KW - VMAT2

UR - http://www.scopus.com/inward/record.url?scp=77954213458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954213458&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2010.04.117

DO - 10.1016/j.bmcl.2010.04.117

M3 - Article

VL - 20

SP - 3584

EP - 3587

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 12

ER -